Phospholipases

Phospholipase inhibitors target enzymes that hydrolyze membrane phospholipids into lipid messengers. Phospholipase A2 (PLA2) enzymes release arachidonic acid, the precursor of prostaglandins and leukotrienes. A cytosolic PLA2 that prefers arachidonic acid was cloned in 1991 and carries a calcium-dependent membrane-binding domain. Phospholipase C (PLC) instead produces inositol trisphosphate and diacylglycerol, two second messengers of receptor signaling. U 73122 was characterized in 1990 as an inhibitor of receptor-coupled, PLC-dependent responses in platelets and neutrophils. D609 is used as an inhibitor of the phosphatidylcholine-specific form of PLC. Varespladib targets secreted PLA2 enzymes, and tanshinone I, a diterpenoid from Salvia miltiorrhiza, is described as a PLA2 inhibitor.

6 Items

  • m-3M3FBS
    Cat. No.
    A30051

    m-3M3FBS

    m-3M3FBS is a potent activator of phospholipase C (PLC). It effectively stimulates superoxide generation in human neutrophils and enhances intracellular calcium concentrations, leading to inositol phosphate production in diverse cell lines. Additionally, m-3M3FBS has been shown to induce apoptosis in monocytic leukemia cells, making it valuable for studying cellular signaling pathways and apoptosis mechanisms in research applications.

    5 mg
    $35.00
    10 mg
    $55.00
    All 5 sizes
  • (S)-Albuterol hydrochloride
    Cat. No.
    A61414

    (S)-Albuterol hydrochloride

    (S)-Albuterol hydrochloride is a selective muscarinic receptor activator that enhances phospholipase C activity. This compound increases intracellular free calcium levels in airway smooth muscle, making it valuable for research on respiratory physiology and pharmacology. Its ability to modulate calcium signaling pathways makes it useful for studying smooth muscle contraction and respiratory function.

    Out of stock

    All 3 sizes
  • 9-Oxononanoic acid
    Cat. No.
    A63073

    9-Oxononanoic acid

    Synonyms: 9-ONA

    9-Oxononanoic acid is a potent phospholipase A2 (PLA2) activator that arises as a secondary product of lipid peroxidation. It stimulates the production of thromboxane A2 (TXA2) and promotes platelet aggregation in human blood, making it a valuable tool for studying platelet function and related cardiovascular processes. Its oral bioavailability enhances its utility in various in vivo research applications.

    1 mg
    $40.00
    5 mg
    $45.00
    All 7 sizes
  • VU534
    Cat. No.
    A74591

    VU534

    VU534 is a potent activator of N-acyl phosphatidylethanolamine-specific phospholipase D (NAPE-PLD), exhibiting an EC50 of 0.30 μM. This compound also functions as a dual inhibitor of fatty acid amide hydrolase (FAAH) and soluble epoxide hydrolase (sEH) with IC50 values of 1.2 μM. VU534 enhances efferocytosis in a NAPE-PLD dependent manner, making it a valuable tool for investigating mechanisms related to cardiometabolic diseases.

    1 mg
    $30.00
    5 mg
    $70.00
    All 6 sizes
  • Compound 48/80
    Cat. No.
    A77094

    Compound 48/80

    Synonyms: Poly-p-methoxyphenethylmethylamine

    Compound 48/80 is a poly-p-methoxyphenethylmethylamine that serves as a selective mast cell activator. It functions at the mast cell membrane by stimulating trimeric G-proteins, leading to degranulation through the activation of phospholipase C and D pathways. This compound is frequently utilized in animal and tissue models for research on mast cell biology and immune responses.

    5 mg
    $30.00
    10 mg
    $45.00
    All 5 sizes
  • VU533
    Cat. No.
    A77125

    VU533

    VU533 is a potent NAPE-PLD activator, with an EC50 value of 0.30 µM. This compound enhances NAPE-PLD activity and promotes efferocytosis in macrophages, making it valuable for investigating mechanisms underlying cardiometabolic diseases. VU533 serves as an important tool for researchers exploring the role of NAPE-PLD in cellular activities and disease progression.

    2 mg
    $30.00
    5 mg
    $50.00
    All 7 sizes

6 Items

Added to your cart

View Cart Checkout

    Loading...